Comprehensive coverage on the latest pharmaceutical regulatory update and industry activities in China.
Sorry, there is no matched result.
- [Updated] China Publishes the Preliminary List of Drugs for 2023 National Reimbursement Drug List (NRDL)
- [Updated] Biopharma Licensing Deals Involving Chinese Companies in H1 2023
- 2022 China CDE Drug Evaluation Report
- [Updated] GLP-1-RAs Swoop to Chinese Market, Eyeing Diabetes Treatment & Weight Control Needs
- Drug Inspections of Manufacturers and Suppliers in China: Regulation Revised